Adaptin Bio (APTN) Operating Expenses (2023 - 2026)

Adaptin Bio's Operating Expenses history runs 4 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 34.53% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $5.7 million (up 82.93% YoY), while the FY2025 annual figure was $5.4 million, up 110.71% from the prior year.
• Operating Expenses came in at $1.1 million for Q1 2026 at Adaptin Bio, down from $1.4 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $1.7 million in Q3 2025 to a low of $4250.0 in Q1 2023.
• A 4-year average of $708813.4 and a median of $767320.0 in 2024 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses jumped 17954.59% in 2024 and jumped 34.53% in 2026, its largest moves.
• Adaptin Bio's Operating Expenses stood at $34155.0 in 2023, then jumped by 1387.57% to $508080.0 in 2024, then surged by 169.25% to $1.4 million in 2025, then slipped by 16.36% to $1.1 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $1.1 million, $1.4 million, and $1.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison